AKT1 and polycystic ovary syndrome: Interestingly, in the PCOS + MSCs + LY294002 group, all parameters deteriorated compared to the PCOS + MSCs rats, indicating that inhibition of the PI3K-AKT signaling pathway completely blocked the beneficial effects of MSCs on PCOS ovaries.